Sol-Gel Technologies Ltd.
SLGL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001684693
In the last 90 days, Sol-Gel Technologies Ltd. insiders filed 8 open-market purchases and 0 sales; 24 institutions reported holding it in 13F filings for Q2 2026, worth $98.1M in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Sol-Gel Technologies Ltd. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 24
- +3 vs. Q1 2026
- Shares held
- 1.32M
- +62.1K (+4.9%) vs. Q1 2026
- Total value
- $98.1M
- −$1.81M (−1.8%) vs. Q1 2026
- New holders
- 5
- 6 more added
- Sold out
- 2
- 7 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SLGL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 24 | $98.1M |
| Q1 2026 | 21 | $100.0M |
| Q4 2025 | 14 | $30.2M |
| Q3 2025 | 10 | $16.3M |
| Q2 2025 | 11 | $4.87M |
| Q1 2025 | 21 | $2.76M |
| Q4 2024 | 17 | $4.86M |
| Q3 2024 | 20 | $3.67M |
| Q2 2024 | 20 | $6.56M |
| Q1 2024 | 20 | $7.56M |
| Q4 2023 | 21 | $9.16M |
| Q3 2023 | 18 | $13.1M |
| Q2 2023 | 17 | $23.6M |
| Q1 2023 | 15 | $31.3M |
| Q4 2022 | 14 | $26.0M |
| Q3 2022 | 13 | $29.5M |
| Q2 2022 | 17 | $23.7M |
| Q1 2022 | 17 | $42.9M |
| Q4 2021 | 18 | $43.3M |
| Q3 2021 | 18 | $58.7M |
| Q2 2021 | 16 | $72.6M |
| Q1 2021 | 20 | $71.3M |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Sol-Gel Technologies Ltd.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Allworth Financial LP | 5 | $371 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 72 | $5.34K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 100 | $7.41K | 0.00% | +100 | New |
| UBS Group AG | 416 | $30.8K | 0.00% | −278−40.1% | Reduced |
| BlackRock, Inc. | 953 | $70.7K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 2,708 | $200.8K | 0.02% | +2,708 | New |
| XTX Topco Ltd | 2,974 | $220.5K | 0.00% | −5,036−62.9% | Reduced |
| Millennium Management LLC | 3,342 | $247.8K | 0.00% | +3,342 | New |
| LPL Financial LLC | 3,904 | $289.4K | 0.00% | +435+12.5% | Added |
| Morgan Stanley | 4,607 | $341.6K | 0.00% | −564−10.9% | Reduced |
| Navellier & Associates Inc | 5,785 | $428.9K | 0.03% | +5,785 | New |
| HRT Financial LP | 6,256 | $463.0K | 0.00% | +3,041+94.6% | Added |
| Menora Mivtachim Holdings Ltd. | 7,611 | $564.3K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 8,357 | $619.6K | 0.00% | +1,205+16.8% | Added |
| Yelin Lapidot Holdings Management Ltd. | 10,384 | $769.9K | 0.15% | −7,369−41.5% | Reduced |
| Stonepine Capital Management, LLC | 14,469 | $1.07M | 0.82% | −13,309−47.9% | Reduced |
| Gilder Gagnon Howe & Co LLC | 22,500 | $1.67M | 0.02% | +22,500 | New |
| Citadel Advisors LLC | 32,556 | $2.41M | 0.00% | −4,589−12.4% | Reduced |
| Squadron Capital Management LLC | 52,000 | $3.86M | 1.32% | +21,000+67.7% | Added |
| Affinity Asset Advisors, LLC | 84,900 | $6.29M | 0.31% | +49,900+142.6% | Added |
| Trails Edge Capital Partners, LP | 139,445 | $10.3M | 1.64% | +53,949+63.1% | Added |
| Phoenix Holdings Ltd. | 146,147 | $10.8M | 0.07% | −64,702−30.7% | Reduced |
| Great Point Partners LLC | 274,363 | $20.3M | 4.79% | 00.0% | Unchanged |
| Opaleye Management Inc. | 500,000 | $37.1M | 3.36% | 00.0% | Unchanged |
| Raymond James Financial Inc | 0 | $0 | 0.00% | −5,733−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −276−100.0% | Sold out |